Study of Correlation of Heamoglobin and Serum Ferritin levels in Psoriasis: Case Control Study
International Journal of Clinical & Experimental Dermatology · 2019
DOI: 10.33140/ijced.04.02.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical & Experimental Dermatology, 2019. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Psoriasis is a chronic, immune-mediated inflammatory skin disease. It ranges in severity from a few scattered red, scaly plaques to involvement of almost the entire body surface. It may progressively worsen with age, or wax and wane in its severity; the degree of severity depends on inheritance and environmental factors [1]. The prevalence of the disease in countries ranges from 0.09% and 11.43% with at least 100 million people affected worldwide. The condition is rarely dangerous to life but it is at all times quite vexatious. A number of people worldwide needlessly suffer from psoriasis due to delayed or incorrect diagnosis, inadequate treatment options, and insufficient access to care and stigmatization [1].
Zitieren
APA
(2019). Study of Correlation of Heamoglobin and Serum Ferritin levels in Psoriasis: Case Control Study. International Journal of Clinical & Experimental Dermatology. https://doi.org/10.33140/ijced.04.02.01
Vancouver
Study of Correlation of Heamoglobin and Serum Ferritin levels in Psoriasis: Case Control Study. International Journal of Clinical & Experimental Dermatology. 2019. doi:10.33140/ijced.04.02.01
BibTeX
@article{euvimed2019,
title = {Study of Correlation of Heamoglobin and Serum Ferritin levels in Psoriasis: Case Control Study},
journal = {International Journal of Clinical & Experimental Dermatology},
year = {2019},
doi = {10.33140/ijced.04.02.01}
}
EUVIMED